Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1

Area of Science:

• Cellular signaling
• Protein ubiquitination
• Receptor biology

Background:

• Receptor desensitization involves accelerated endocytosis and degradation of ligand-receptor complexes.
• The epidermal growth factor receptor (EGFR) is a key mediator of cell growth and survival.
• Cbl adaptor proteins are known to be involved in protein trafficking and signaling regulation.

Purpose of the Study:

• To elucidate the role of Cbl adaptor proteins in the downregulation of the epidermal growth factor receptor (EGFR).
• To investigate the molecular mechanisms by which Cbl proteins mediate EGFR desensitization.
• To identify the functional domains of Cbl proteins critical for EGFR ubiquitination and degradation.

Main Methods:

• Utilized an in vitro reconstituted system to study Cbl-mediated EGFR regulation.
• Investigated protein-protein interactions and post-translational modifications (e.g., phosphorylation, ubiquitination).
• Employed oncogenic Cbl variants with defective functional domains to assess their impact on EGFR desensitization.

Main Results:

• Cbl adaptor proteins directly control EGFR downregulation by recruiting ubiquitin-activating and -conjugating enzymes.
• EGFR autophosphorylation at a lysosome-targeting motif initiates Cbl recruitment, followed by c-Cbl tyrosine phosphorylation.
• This sequential process leads to EGFR ubiquitination and subsequent degradation, with all three Cbl family members enhancing ubiquitination.

Conclusions:

• Cbl proteins are essential components of the ubiquitin ligation machinery that mediate EGFR desensitization.
• Specific functional domains within Cbl proteins, including the RING finger and phosphorylation sites, are critical for this process.
• The findings imply that Cbl proteins similarly regulate other signaling pathways by controlling receptor ubiquitination and degradation.